115 related articles for article (PubMed ID: 28641622)
1. [Variation of LNK Gene in Chronic Myeloid Leukemia].
Tan M; Rong Y; Tian RM; Zhu YH; Zhu P; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):706-710. PubMed ID: 28641622
[TBL] [Abstract][Full Text] [Related]
2. The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.
Chen Y; Fang F; Hu Y; Liu Q; Bu D; Tan M; Wu L; Zhu P
PLoS One; 2016; 11(4):e0154183. PubMed ID: 27111338
[TBL] [Abstract][Full Text] [Related]
3. [Variation and Clinical Significance of LNK Gene in Essential Thrombocytosis].
Tian RM; Rong Y; Wu LS; Jiang Y; Qing HY; Zhu P; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):228-233. PubMed ID: 29397849
[TBL] [Abstract][Full Text] [Related]
4. [LNK Gene Single Nucleotide Polymorphisms and Acute Leukemia Susceptibility].
Wu LS; Han CS; Tan M; Zhu P; Bu FD; Zhang Y; Chen Y; Wu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1305-1311. PubMed ID: 27784347
[TBL] [Abstract][Full Text] [Related]
5. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.
Ferri C; Weich N; Gutiérrez L; De Brasi C; Bengió MR; Zapata P; Fundia A; Larripa I
Gene; 2019 Apr; 694():71-75. PubMed ID: 30738963
[TBL] [Abstract][Full Text] [Related]
7. Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia.
Gupta M; Milani L; Hermansson M; Simonsson B; Markevärn B; Syvänen AC; Barbany G
Biochem Biophys Res Commun; 2008 Feb; 366(3):848-51. PubMed ID: 18082628
[TBL] [Abstract][Full Text] [Related]
8. Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
Saussele S; Weisser A; Müller MC; Emgi M; La Rosée P; Paschka P; Kuhn C; Willer A; Hehlmann R; Hochhaus A
Leukemia; 2000 Nov; 14(11):2006-10. PubMed ID: 11069038
[TBL] [Abstract][Full Text] [Related]
9. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Viswanathan K; Roboz G; Chadburn A; Mathew S
Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
[TBL] [Abstract][Full Text] [Related]
10. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
[TBL] [Abstract][Full Text] [Related]
11. New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Mascarenhas CC; Cunha AF; Miranda EC; Zulli R; Silveira RA; Costa FF; Pagnano KB; De Souza CA
Leuk Lymphoma; 2009 Jul; 50(7):1148-54. PubMed ID: 19557636
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
13. [Association of CD38 gene polymorphism with pathogenesis of chronic myeloid leukemia].
Li J; Zhu JF; Zhang W; Ma HZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):284-7. PubMed ID: 21518472
[TBL] [Abstract][Full Text] [Related]
14. The Association of rs2114358 in the miR-1206 Polymorphism to Chronic Myeloid Leukemia.
Hassan FM
Microrna; 2019; 8(3):248-252. PubMed ID: 30605069
[TBL] [Abstract][Full Text] [Related]
15. Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
Cavelier L; Ameur A; Häggqvist S; Höijer I; Cahill N; Olsson-Strömberg U; Hermanson M
BMC Cancer; 2015 Feb; 15():45. PubMed ID: 25880391
[TBL] [Abstract][Full Text] [Related]
16. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
17. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
Moore FR; Yang F; Press RD
Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
[TBL] [Abstract][Full Text] [Related]
18.
Meza-Espinoza JP; Vásquez-Jiménez EA; Barajas-Torres RL; Magaña-Torres MT; González-García JR
Ann Clin Lab Sci; 2019 Nov; 49(6):703-709. PubMed ID: 31882420
[No Abstract] [Full Text] [Related]
19. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
20. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
